Stephen V Faraone Selected Research

Stephen V Faraone Research Topics

Disease

223	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2024 - 01/2002
30	Schizophrenia (Dementia Praecox) 01/2022 - 02/2002
16	Bipolar Disorder (Manic Depressive Psychosis) 02/2024 - 07/2002
13	Substance-Related Disorders (Drug Abuse) 01/2016 - 01/2003
10	Mania (Manias) 10/2022 - 05/2006
8	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 05/2004
5	Mood Disorders (Mood Disorder) 02/2024 - 01/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 09/2012
4	Autism Spectrum Disorder 02/2024 - 06/2016
4	Antisocial Personality Disorder (Antisocial Personality) 01/2020 - 12/2007
4	Conduct Disorder (Conduct Disorders) 01/2019 - 02/2009
3	Genetic Risk Score 11/2023 - 01/2016
3	Hypertension (High Blood Pressure) 06/2023 - 01/2002
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2004
3	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 10/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2019 - 07/2012
3	Autistic Disorder (Autism) 06/2016 - 01/2012
3	Anxiety Disorders (Anxiety Disorder) 02/2015 - 11/2009
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2014 - 03/2006
3	Tics (Tic) 01/2004 - 01/2002
2	Tic Disorders (Tic Disorder) 02/2024 - 07/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 03/2011
2	COVID-19 01/2023 - 12/2022
2	Neurodevelopmental Disorders 01/2022 - 01/2020
2	Sleep Wake Disorders 01/2021 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2021 - 04/2014
2	Epilepsy (Aura) 01/2021 - 07/2010
2	Oppositional Defiant Disorder 01/2019 - 02/2009
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Panic Disorder (Panic Attack) 12/2014 - 06/2005
2	Overweight 10/2013 - 09/2008

Drug/Important Bio-Agent (IBA)

40	Methylphenidate (Ritalin)FDA LinkGeneric 02/2024 - 06/2002
19	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2002
17	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 07/2004
16	Amphetamine (Amfetamine)FDA LinkGeneric 04/2024 - 04/2005
14	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2023 - 01/2002
13	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 01/2004
12	Lisdexamfetamine Dimesylate FDA Link 01/2021 - 06/2008
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2012
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2004
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2017 - 02/2005
8	ViloxazineIBA 04/2024 - 01/2021
8	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 09/2003
7	SaltsIBA 01/2024 - 04/2005
7	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2005
7	3' Untranslated Regions (3' UTR)IBA 10/2013 - 04/2007
7	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2013 - 07/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2004
5	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 01/2022 - 05/2006
5	Nicotine FDA Link 01/2016 - 04/2002
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013 - 01/2002
4	Guanfacine (Tenex)FDA LinkGeneric 01/2023 - 03/2010
4	AmphetaminesIBA 01/2018 - 03/2003
4	Indicators and Reagents (Reagents)IBA 01/2018 - 09/2002
4	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 02/2006
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 07/2013 - 08/2005
4	SmokeIBA 09/2012 - 04/2002
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009 - 05/2007
4	EnzymesIBA 06/2007 - 04/2003
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2007 - 03/2003
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 05/2004
3	Genetic Markers (Genetic Marker)IBA 11/2023 - 04/2008
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 10/2006
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2022 - 09/2012
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2013
3	4-aminospiroperidolIBA 10/2018 - 12/2007
3	Naltrexone (ReVia)FDA LinkGeneric 03/2018 - 10/2014
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 09/2013
3	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2017 - 04/2014
3	BenzodiazepinesIBA 02/2015 - 02/2012
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2014 - 11/2008
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2013 - 12/2011
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2013 - 01/2002
3	Monoamine Oxidase (MAO)IBA 10/2012 - 06/2007
3	AdderallIBA 07/2007 - 06/2002
3	Serotonin ReceptorsIBA 07/2006 - 01/2006
3	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2006 - 03/2002
2	CreatinineIBA 06/2023 - 01/2018
2	Clonidine (ST 155)FDA LinkGeneric 01/2023 - 02/2015
2	ORALIT (ORS)IBA 10/2022 - 01/2021
2	Inositol (Myoinositol)IBA 10/2022 - 11/2015
2	Antimanic AgentsIBA 01/2022 - 08/2011
2	ApolipoproteinsIBA 01/2022 - 03/2010
2	Opioid Analgesics (Opioids)IBA 01/2020 - 10/2014
2	Cocaine (Cocaine HCl)IBA 01/2019 - 06/2006
2	Narcotic Antagonists (Opioid Antagonists)IBA 03/2018 - 01/2018
2	TOR Serine-Threonine KinasesIBA 01/2018 - 09/2012
2	Opiate AlkaloidsIBA 01/2018 - 06/2006
2	Memantine (Namenda)FDA Link 01/2017 - 06/2016
2	Protons (Proton)IBA 04/2016 - 08/2005
2	SodiumIBA 04/2016 - 10/2013
2	Messenger RNA (mRNA)IBA 01/2016 - 04/2005
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2016 - 10/2006
2	RNA (Ribonucleic Acid)IBA 10/2015 - 12/2008
2	alpha-2 Adrenergic ReceptorsIBA 11/2013 - 03/2006
2	Sodium-Hydrogen ExchangersIBA 10/2013 - 01/2012

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
17	Therapeutics 04/2024 - 07/2002
4	Aftercare (After-Treatment) 01/2019 - 10/2005